Journal profile · ENDOCRINOLOGY & METABOLISM
Current Opinion in Endocrinology Diabetes and Obesity
ISSN 1752-296X · eISSN 1752-2978 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Founded 2007
Current Opinion in Endocrinology Diabetes and Obesity: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.56; JCR Q2 (journal website); hybrid open access; review 6–12 weeks (community reports); 45 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Current Opinion in Endocrinology Diabetes and Obesity is published by Lippincott Williams and Wilkins Ltd. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes and associated disorders and Pancreatic function and diabetes, together about 18.2% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Current Opinion in Endocrinology, Diabetes and Obesity delivers a broad-based perspective on the most recent and exciting developments in the field from across the world. Published bimonthly and featuring twelve key topics – including androgens, gastrointestinal hormones, diabetes and the endocrine pancreas, and neuroendocrinology – the journal’s renowned team of guest editors ensure a balanced, expert assessment of the recently published literature in each respective field with insightful editorials and on-the-mark invited reviews.
Source: LetPub
Research area (LetPub): ENDOCRINOLOGY & METABOLISM
Editor-in-chief Gerald F. WattsPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine6.3%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology6.3%
- Pancreatic function and diabetesMedicine5.7%
- Thyroid Disorders and TreatmentsMedicine5.5%
- Diabetes Management and ResearchMedicine5.2%
- Hormonal and reproductive studiesMedicine5%
- Regulation of Appetite and ObesityNeuroscience4.8%
- Pituitary Gland Disorders and TreatmentsMedicine4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: yes
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · ENDOCRINOLOGY & METABOLISM · rank 87/198
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.56LetPub ·
- Impact factor (publisher)
- 3.5Publisher website ·
- CiteScore 2026-06
- 6.2LetPub ·
- SJR 2026-06
- 0.98LetPub ·
- SNIP 2026-06
- 1.01LetPub ·
- h-index
- 57LetPub ·
- h-index
- 102OpenAlex ·
- i10-index
- 931OpenAlex ·
- 2-year mean citedness
- 3.5OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 5.22%LetPub ·
Volume
- Articles per year
- 36LetPub ·
Articles by year OpenAlex count · 1,498 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 26 | 1 | 10 |
| 2025 | 45 | 4 | 111 |
| 2024 | 41 | 7 | 271 |
| 2023 | 51 | 13 | 483 |
| 2022 | 82 | 27 | 930 |
| 2021 | 86 | 36 | 1,179 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Founded
- 2007
- ISSN
- 1752-296X
- Electronic ISSN
- 1752-2978
- Latest issue on the website
- Volume 33, Issue 5 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Current Opinion in Endocrinology Diabetes and Obesity
What CAS zone is Current Opinion in Endocrinology Diabetes and Obesity in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Opinion in Endocrinology Diabetes and Obesity is in Zone 3 of Medicine, and in Zone 4 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Opinion in Endocrinology Diabetes and Obesity?
The latest impact factor listed by LetPub is 3.56; CiteScore 6.2, h-index 102.
How long does peer review take at Current Opinion in Endocrinology Diabetes and Obesity?
Authors report an average review time of 6–12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Current Opinion in Endocrinology Diabetes and Obesity in?
The journal's website gives JCR Q2; by category, ENDOCRINOLOGY & METABOLISM Q2 (87/198). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Medicine.
Which databases index Current Opinion in Endocrinology Diabetes and Obesity?
According to LetPub and DOAJ records, Current Opinion in Endocrinology Diabetes and Obesity is indexed in SCIE and Scopus.
Is Current Opinion in Endocrinology Diabetes and Obesity open access, and what is the APC?
Current Opinion in Endocrinology Diabetes and Obesity is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .